Polymer Factory Sweden AB receives order of approx. SEK 540,000 from a global life science company

Report this content

Polymer Factory today announces an order of significant size, as a global life science company has placed an order amounting to approximately SEK 540,000. The order is placed as a next phase of evaluations, following an order that was announced in January 2022. 

Purchasing products from Polymer Factory’s portfolio of dendritic nanomaterials, one of the world’s largest life science companies has placed an order of EUR 52,000, amounting to approximately SEK 540,000. The products purchased are customized and will be used by the customer for product development purposes, and the order is a result of successful evaluation of previously delivered products.

Products are expected to be delivered to the customer during Q3 2022 and may lead to continued business opportunities upon successful product development. 

About Polymer Factory

Polymer Factory was founded in 2006 at KTH Royal Institute of Technology and its Board of Directors have been essential in driving dendritic nanotechnology research to commercialization for almost 15 years – expertise that has been transferred to the Company’s products. Emerging from many years of cutting-edge research within the field, Polymer Factory today has, in the Company’s assessment, the world’s largest product portfolio of dendritic materials with customers ranging from Big Pharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. Polymer Factory has also used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments.

This disclosure contains information that Polymer Factory is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 06-07-2022 13:59 CET.

For more information about Polymer Factory, please contact:
Elin Mignérus, CEO
Phone: +46 (0) 79 300 27 76
E-mail: elin.mignerus@polymerfactory.com

Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.

Subscribe

Documents & Links

Quotes

Our dendritic nanomaterial platform has unlimited potential in the life science sector, ranging from therapeutic to diagnostic applications. The fact is, since becoming a public Company, we have secured customized orders of significant size from two global life science companies. This foretells the demand and interest for our dendritic products among life science companies and underlines the quality and unique position of our Company. The Company’s goal is to help our customers succeed by leveraging the benefits of dendritic amplification, and we are always working to bring these collaborations into long-term relationships.
Elin Mignérus, CEO